Management of Distal Symmetric Polyneuropathy in 2020
This JAMA Insights Clinical Update reviews the diagnosis and management of distal symmetric neuropathy, including control of risk factors (eg, high glucose in type 1 diabetes, weight loss) and use of nonpharmacologic and pharmacologic therapies (eg, SNRIs, tricyclic antidepressants, gabapentinoids).
Source: JAMA - Category: General Medicine Source Type: research
More News: Brain | Diabetes | Diabetes Type 1 | Endocrinology | General Medicine | Neurology | Weight Loss